The study is to assess treatment with sofosbuvir, velpatasvir and voxilaprevir (Vosevi) in people who were previously treated with a direct-acting antiviral medication but who were not cured. Epclusa plus GS-9857 are the drugs being tested.
Safety, Tolerability and Efficacy of Sofosbuvir, Velpatasvir, and Voxilaprevir (Vosevi) in Subjects With Previous DAA Experience (RESOLVE)
To view the entire clinical trial information, click here
Share This Page